So far the results have been exactly as expected. The management has been saying 4Q 2019 or 1Q 2020 for a long time. They have not changed that plan as far as I can tell. If it's 2Q 2020 and there is no progress than I would be a little skeptical. At this point however they haven't missed anything.
Would I as a shareholder like more updates sure...but if those updates are just fluff stating the same facts over again I would prefer for them to hold them until the news is impactful. The patience on these development stage companies is very difficult to endure and takes a certain type of investor. If someone invested and expected revenues at the development stage that is on them for not doing their proper research.
There are 100's of pharma companies that trade on forward looking sentiment rather than revenues. It's the nature of the industry...thinking otherwise again is on the investor for not educating themselves on how the industry works.
News 
Market Data 
Discover 
AI
